Sudafed, Tylenol, DayQuil, NyQuil and Store Brand Cold and Flu Medicines
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Clay et al. v. The Procter & Gamble Co.
21-cv-11133, S.D.N.Y.
(Dec. 2021)
DayQuil medicines containing dextromethorphan hydrobromide (DXM)\
Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness
Pending
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Misleadingly marketing products as if they alleviate cold and flu symptoms when fine print on the side of the product packaging discloses that the products are “not intended to…
Allegations: Falsely marketing medicine as “non-drowsy” when an ingredient causes drowsiness
MADISON, CONN. August 22, 2019– Consumer advocacy organization, truthinadvertising.org (TINA.org), filed a formal petition today requesting that the Federal Trade Commission (FTC) use its rulemaking authority to expand its enforcement…
A review of TINA.org’s work uncovering (and putting an end to) deceptive made in the USA ad campaigns.
TINA.org found the German automaker didn’t have the support to claim its Sprinter van was “built in the USA.”
These brand-relationship disclosures are far from world-class.
Instant replay shows six instances in which Super Bowl 52 advertisers have fumbled ad claims.